We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 41.61%
This Fund
S&P 500
This Quarter Est. Return
+12.1%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$2.82B
AUM Growth
+$234M
Cap. Flow
-$1.4M
Cap. Flow %
-0.05%
Top 10 Hldgs %
24.26%
Holding
155
New
8
Increased
61
Reduced
51
Closed
11

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$30.7M
2
NFLX icon
Netflix
NFLX
+$30.1M
3
PEP icon
PepsiCo
PEP
+$29.5M
4
TKR icon
Timken Company
TKR
+$28.6M
5
SLB icon
SLB Ltd
SLB
+$21M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$31M
2
PLUG icon
Plug Power
PLUG
+$26.8M
3
JPM icon
JPMorgan Chase
JPM
+$26M
4
AMZN icon
Amazon
AMZN
+$21M
5
GNRC icon
Generac Holdings
GNRC
+$18.6M

Sector Composition

Rank Sector Weight
1 Industrials 20.09%
2 Technology 19.96%
3 Healthcare 13.75%
4 Financials 13.06%
5 Consumer Staples 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
1
Deere & Co
DE
$162B
$76.2M 2.7%
177,752
-2,722
-2% -$1.11M
SCHW
2
Charles Schwab
SCHW
$181B
$76M 2.7%
913,074
+1,464
+0.2% +$114K
TDY icon
3
Teledyne Technologies
TDY
$30.1B
$74.5M 2.64%
186,298
+2,420
+1% +$942K
AAPL icon
4
Apple
AAPL
$4.9T
$71.1M 2.52%
547,564
-6,506
-1% -$930K
HD icon
5
Home Depot
HD
$332B
$67M 2.37%
212,020
+2,065
+1% +$629K
HON icon
6
Honeywell
HON
$76.7B
$66.2M 2.35%
327,571
-3,204
-1% -$612K
TMO icon
7
Thermo Fisher Scientific
TMO
$214B
$64.6M 2.29%
117,324
+2,296
+2% +$1.22M
MSFT icon
8
Microsoft
MSFT
$3.35T
$63M 2.23%
262,732
+3,771
+1% +$905K
COST icon
9
Costco
COST
$423B
$62.8M 2.23%
137,473
+1,810
+1% +$884K
AVY icon
10
Avery Dennison
AVY
$13.4B
$62.7M 2.22%
346,607
+1,598
+0.5% +$285K
LLY icon
11
Eli Lilly
LLY
$1.03T
$61.1M 2.17%
167,054
-3,605
-2% -$1.28M
LMT icon
12
Lockheed Martin
LMT
$132B
$60.9M 2.16%
125,163
-1,931
-2% -$897K
TXN icon
13
Texas Instruments
TXN
$255B
$60.4M 2.14%
365,805
+2,050
+0.6% +$342K
UNP icon
14
Union Pacific
UNP
$172B
$58.9M 2.09%
284,662
-1,840
-0.6% -$377K
PG icon
15
Procter & Gamble
PG
$335B
$58.1M 2.06%
383,347
-1,346
-0.3% -$189K
MKC icon
16
McCormick & Company Non-Voting
MKC
$13.7B
$57.6M 2.04%
694,919
+8,646
+1% +$697K
SPGI icon
17
S&P Global
SPGI
$122B
$55.6M 1.97%
165,942
+1,580
+1% +$521K
ADP icon
18
Automatic Data Processing
ADP
$105B
$55.6M 1.97%
232,683
+128
+0.1% +$31.4K
TTEK icon
19
Tetra Tech
TTEK
$8.42B
$55.2M 1.96%
1,901,375
-200
-0% -$5.78K
JNJ icon
20
Johnson & Johnson
JNJ
$617B
$52.9M 1.88%
299,567
+3,554
+1% +$614K
ZTS icon
21
Zoetis
ZTS
$31.9B
$51.4M 1.82%
350,782
+23,005
+7% +$3.4M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$122B
$50.6M 1.79%
175,210
-5,800
-3% -$1.77M
MRSH
23
Marsh
MRSH
$91.4B
$49.1M 1.74%
296,880
+38,562
+15% +$6.31M
ISRG icon
24
Intuitive Surgical
ISRG
$126B
$49.1M 1.74%
185,130
+11,710
+7% +$2.86M
V icon
25
Visa
V
$673B
$48.8M 1.73%
235,015
+3,082
+1% +$622K

Similar funds

Bowen Hanes & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Bowen Hanes & Co held 155 positions worth $2.82B, up 9% from $2.59B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bowen Hanes & Co's Q4 2022 filing shows 8 new, 61 increased, 51 reduced and 11 closed positions. Its largest new stake was MetLife: 428,510 shares worth $31M. The largest sale was Walt Disney, an estimated $31M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • Bowen Hanes & Co's largest Q4 2022 buy was MetLife: 428,510 shares worth $31M.
  • Bowen Hanes & Co added most to PepsiCo in Q4 2022, an estimated $29.5M increase.
  • Bowen Hanes & Co's biggest Q4 2022 reduction was Walt Disney, cutting an estimated $31M.
  • Bowen Hanes & Co fully exited Plug Power in Q4 2022, selling an estimated $26.8M.
  • Bowen Hanes & Co's ten largest holdings make up 24% of its $2.82B portfolio in Q4 2022.
  • Bowen Hanes & Co opened 8 new positions and closed 11 in Q4 2022.
  • Bowen Hanes & Co's portfolio value rose 9% quarter-over-quarter to $2.82B.

Based on Bowen Hanes & Co's 13F filing for Q4 2022, filed 9 Feb 2023.